$77bn in the US, Japan, the five major EU markets ( France, Germany, Italy, Spain, and the UK), the BRIC markets ( Brazil, Russia, India, and China), and Australia combined. With branded pharma set to lose approximately $100bn in sales due to the patent...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent Cliff Set To Drive Global Generic Uptake Despite Tougher Market Conditions
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account